Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
JCI Insight|December 13, 2016
Development of an in vitro human liver system for interrogating nonalcoholic steatohepatitisRyan E Feaver, Banumathi K Cole, Mark J Lawson, et al.
Stem Cells Translational Medicine|June 20, 2017
Exposure of Induced Pluripotent Stem Cell-Derived Vascular Endothelial and Smooth Muscle Cells in Coculture to Hemodynamics Induces Primary Vascular Cell-Like PhenotypesMaria S Collado, Banumathi K Cole, Robert A Figler, et al.
Chemico-Biological Interactions|December 3, 2015
Transcriptional profiling suggests that Nevirapine and Ritonavir cause drug induced liver injury through distinct mechanisms in primary human hepatocytesYlva Terelius, Robert A Figler, Svetlana Marukian, et al.
Diabetes|January 29, 2011
Links between insulin resistance, adenosine A2B receptors, and inflammatory markers in mice and humansRobert A Figler, Guoquan Wang, Susseela Srinivasan, et al.
American Journal of Medical Genetics. Part A|July 8, 2022
Genomic and biochemical analysis of repeatedly observed variants in DBT in individuals with maple syrup urine disease of Central American ancestryCharles J Billington, Kimberly A Chapman, Eyby Leon, et al.
Molecular Genetics and Metabolism|January 8, 2016
Recapitulation of metabolic defects in a model of propionic acidemia using patient-derived primary hepatocytesKimberly A Chapman, Maria S Collado, Robert A Figler, et al.
Lab on a Chip|March 7, 2019
Development of a multicellular pancreatic tumor microenvironment system using patient-derived tumor cellsDaniel Gioeli, Chelsi J Snow, Michael B Simmers, et al.
Plos One|September 8, 2023
Human cardiovascular disease model predicts xanthine oxidase inhibitor cardiovascular riskRyan E Feaver, M Scott Bowers, Banumathi K Cole, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 22, 2015
An In Vitro Cynomolgus Vascular Surrogate System for Preclinical Drug Assessment and Human TranslationBanumathi K Cole, Michael B Simmers, Ryan Feaver, et al.
Journal of Medicinal Chemistry|April 13, 2021
Identification of 2,2-Dimethylbutanoic Acid (HST5040), a Clinical Development Candidate for the Treatment of Propionic Acidemia and Methylmalonic AcidemiaAllison J Armstrong, Brad R Henke, Maria Sol Collado, et al.
Pageof 3